Alexander Beadle has been working as a freelance science writer since 2017 and has covered the cannabis industry for Analytical Cannabis since 2018. He has also written for our sister publication, Technology Networks, and the cannabis industry consultant firm Prohibition Partners, among others. Alexander holds an MChem in materials chemistry from the University of St Andrews, where he won a Chemistry Purdie Scholarship and conducted research into zeolite crystal growth mechanisms and the action of single-molecule transistors.
Latest Content From Alexander Beadle
With over 70 known cannabinoids present in the cannabis plant, it's important that researchers and testing staff look at more than just the THC content when examining cannabis material. But how exactly do analysts profile and study these dozens of cannabinoids?VIEW
With many businesses now experiencing disruption caused by the ongoing coronavirus pandemic, Matthew Anderson of Vanguard Scientific tells Analytical Cannabis of his experiences working in the supply chain over the past several months.VIEW
Product testing conducted by the US Food and Drug Administration (FDA) has found that many CBD-infused products on sale in the United States are mislabeled, containing vastly differing amounts of CBD than advertised on the product packaging.VIEW
New sample collectors will be allowed to collect samples of cannabis and cannabis products for testing on behalf of the state’s cannabis testing facilities.VIEW
The bills still face several more months of debate before they can become a law, but this latest action still represents a meaningful step forward for cannabis law reform in Israel.VIEW
LYPHE Group announced a new partnership with Eaststone Ltd to secure import, distribution, and other ancillary services relating to the cannabis sector in the United Kingdom.VIEW
The registry aims to collect and analyze clinical information from patients taking medical cannabis treatments in the UK for all recognized eligible conditions.VIEW
Written by some of the country’s top drug science and policy researchers, the review puts forward a number of ‘next steps’ for the country to consider pursuing in order to better support prospective medical cannabis patients in the UK.VIEW
Researchers at George Mason University have received $450,000 in funding from the National Institutes of Health to pursue new research into whether cannabinoids can help treat HIV-associated disorders.VIEW
Initially scheduled to begin in September, the need to tackle the coronavirus pandemic means that the medical cannabis program will be postponed until January 2021 at the latest.